Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 12/20 | 0.50 |
| ▸ | TSHR | P16473 | 10/20 | 0.50 |
| ▸ | HPGD | P15428 | 8/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TTR | P02766 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11234833 | 0.79 | HSD17B10 (0.57) | HSD17B10TSHRHPGDCYP3A4ALDH1A1 | |
| SCHEMBL11879785 | 0.79 | HSD17B10 (0.57) | HSD17B10TSHRHPGDCYP3A4ALDH1A1 | |
| SCHEMBL9099561 | 0.79 | HSD17B10 (0.63) | HSD17B10TSHRHPGDCYP3A4ALDH1A1 | |
| SCHEMBL1961108 | 0.75 | SELL (0.47) | HSD17B10HPGDCYP3A4ALDH1A1TTR | |
| SCHEMBL4450834 | 0.75 | HSD17B10 (0.43) | HSD17B10TSHRHPGDCYP3A4ALDH1A1 | |
| SCHEMBL69390 | 0.73 | HSD17B10 (0.65) | HSD17B10TSHRHPGDCYP3A4ALDH1A1 | |
| SCHEMBL70606 | 0.73 | HSD17B10 (0.65) | HSD17B10TSHRHPGDCYP3A4ALDH1A1 | |
| SCHEMBL70194 | 0.73 | HSD17B10 (0.72) | HSD17B10TSHRHPGDCYP3A4ALDH1A1 | |
| SCHEMBL12804729 | 0.73 | HSD17B10 (0.55) | HSD17B10TSHRHPGDCYP3A4ALDH1A1 | |
| SCHEMBL70334 | 0.72 | HSD17B10 (0.73) | HSD17B10TSHRHPGDCYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370158-A1 | PORPHYRIN NANOVESICLE WITH FATTY ACID CONJUGATE | University Health Network (CA) | 2024-05-22 | — | — | EP | claimed |
| CN-117980004-A | Porphyrin nanovesicles with fatty acid conjugates | 大学健康网络 | 2024-05-03 | — | — | CN | claimed |
| WO-2023283732-A1 | PORPHYRIN NANOVESICLE WITH FATTY ACID CONJUGATE | UNIVERSITY HEALTH NETWORK (CA) | 2023-01-19 | — | — | WO | claimed |
| WO-2020125119-A1 | AQUEOUS CAPSULES AND PREPARATION METHOD THEREFOR | 云南巴菰生物科技有限公司 | 2020-06-25 | — | — | WO | claimed |
| CN-106474474-B | Photo-thermal nano particle based on peptide and photosensitizer, preparation method and application thereof | 中国科学院过程工程研究所 | 2020-02-14 | — | — | CN | claimed |
| US-20190307893-A1 | NANOVESICLES WITH PORPHYRIN-LIPID CONJUGATE CORE | UNIVERSITY HEALTH NETWORK (CA) | 2019-10-10 | — | — | US | claimed |
| WO-2019136118-A2 | CELL-ASSOCIATING IMMUNOLOGIC ADJUVANTS FOR TREATMENT ENHANCEMENT | ACADEMIA SINICA (TW) | 2019-07-11 | — | — | WO | claimed |
| EP-2717857-B1 | METHOD FOR THE SYNTHESIS OF PORPHYRIN-PHOSPHOLIPID CONJUGATES | UNIV HEALTH NETWORK UHN (CA) | 2018-07-11 | — | — | EP | claimed |
| EP-3310387-A1 | SPECIFIC PHOTOIMMUNO-THERANOSTICS FOR DETECTION AND ELIMINATION OF SKIN CANCER CELLS | Fraunhofer Gesellschaft zur Förderung der Angewand (DE) | 2018-04-25 | — | — | EP | claimed |
| EP-2488206-B1 | PORPHYRIN NANOVESICLES | UNIV HEALTH NETWORK UHN (CA) | 2018-03-21 | — | — | EP | claimed |
| EP-1993356-A2 | ORAL DELIVERY OF THERAPEUTIC AGENTS USING TIGHT JUNCTION AGONISTS | Alba Therapeutics Corp. (US) | 2008-11-26 | — | — | EP | claimed |
| EP-1933875-A2 | CONJUGATES OF PHOTOSENSITISERS AND ANTIBODIES | Photobiotics Limited (GB) | 2008-06-25 | — | — | EP | claimed |
| WO-2007095091-A2 | ORAL DELIVERY OF THERAPEUTIC AGENTS USING TIGHT JUNCTION AGONISTS | ALBA THERAPEUTICS CORPORATION (US) | 2007-08-23 | — | — | WO | claimed |
| WO-2007042775-A2 | CONJUGATES OF PHOTOSENSITISERS AND ANTIBODIES | PHOTOBIOTICS LIMITED (GB) | 2007-04-19 | — | — | WO | claimed |
| WO-2006133271-A2 | COMPOSITIONS AND METHODS RELATING TO TARGET-SPECIFIC PHOTODYNAMIC THERAPY | THE GENERAL HOSPITAL CORPORATION (US) | 2006-12-14 | — | — | WO | claimed |
| US-20060013454-A1 | Systems for identifying, displaying, marking, and treating suspect regions of tissue | MEDISPECTRA, INC. (US) | 2006-01-19 | — | — | US | claimed |
| US-20050154277-A1 | Apparatus and methods of using built-in micro-spectroscopy micro-biosensors and specimen collection system for a wireless capsule in a biological body in vivo | TANG JING (US) | 2005-07-14 | — | — | US | claimed |
| US-20050148842-A1 | Positioning devices and methods for in vivo wireless imaging capsules | WANG LEMING (US) | 2005-07-07 | — | — | US | claimed |
| WO-2004032803-A1 | STENT WITH RING ARCHITECTURE AND AXIALLY DISPLACED CONNECTOR SEGMENTS | COOK INCORPORATED (US) | 2004-04-22 | — | — | WO | claimed |
| WO-1997040888-A1 | THERAPY APPARATUS AND METHOD | GLAXO GROUP LIMITED (GB) | 1997-11-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190307893-A1 | NANOVESICLES WITH PORPHYRIN-LIPID CONJUGATE CORE | PHOSPHO1, PCYT1A, CLTB | HSD17B10 629/4885TSHR 1358/4885HPGD 3115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.